 |
Articles
Oncology, Pain Relief and Government
The World Health Organization (WHO) says that most pain due to cancer could be relieved using a simple analgesic approach, i.e., oral morphine, and that every national government should institute a cancer pain relief program.(1) The WHO analgesic method has also been endorsed for relief of pain due to HIV/AIDS.(2) The method depends on opioid availability and patient access to essential opioid medicines. Recognizing that opioids are controlled strictly as narcotic drugs because of a potential for abuse and drug dependence, WHO recommended that governments (a) evaluate their drug control policies and practices to ensure that patients receive the opioid medications that are necessary for pain relief, and (b) encourage health care workers to report to the appropriate authorities any instance in which oral opioids are not available for cancer patients.
Indeed, the fact that opioids are narcotic drugs regulated by governments is why those interested in pain relief and palliative care for HIV/AIDS and cancer must learn about the drug regulatory system and prepare to work with governments.
The World Health Assembly and the United Nations (UN) Economic and Social Council have become concerned about disparities in availability and patient access to medications such as morphine (Table 1). These UN bodies have adopted resolutions aimed at improving the availability of essential opioid medications for pain relief, especially in low- and middle-income countries.(3,4) The WHO has also published guidelines for improving the availability of opioid analgesics in the world, entitled “Achieving Balance in National Opioids Control Policy: Guidelines for Assessment.” This document provides 16 guidelines that should be used by governments and health professionals in all countries to assess the national opioids control policies and the administration of such policies in order to determine whether they contain the necessary provisions and procedures and promote the required level of cooperation necessary to ensure the availability of opioid analgesics. The guidelines are based on the international legal and medical principle of balance i.e, that efforts to prevent drug abuse and diversion must not interfere with the adequate availability of opioid analgesics for pain relief.
These Guidelines are available in 22 languages, including Arabic, Bulgarian, Chinese, English, French, German, Hindi, Indonesian, Italian, Lithuanian, Mongolian, Polish, Portuguese, Romanian, Russian, Serbian, Spanish, Swahili, Tagalog, Turkish, Ukrainian and Vietnamese, and can be accessed through the Pain & Policy Studies Group website at http://www.painpolicy.wisc.edu/publicat/00whoabi/00whoabi.htm
As a World Health Organization Collaborating Center, the Pain & Policy Studies Group (PPSG) at the University of Wisconsin has been working in many parts of the world, including India, Italy, Romania and Africa, using the Guidelines to develop effective methods of identifying and overcoming barriers to opioid availability.
India: PPSG assisted palliative care experts and national and state governments to identify regulatory barriers to the availability of opioid analgesics for use in palliative care. National and state policies have begun to change and the long decline in morphine use has been reversed in some areas; there has been little or no morphine abuse or diversion. See published articles: http://www.painpolicy.wisc.edu/publicat/02jpsm3/index.htm;;
http://www.painpolicy.wisc.edu/publicat/01lancet/contents.htm;
Italy: PPSG assisted the Ministry of Health to identify barriers to opioid availability, culminating in new legislation and drug registration procedures, new and previously unavailable medications were added to the list of reimbursable drugs and funds were provided for physician education and public awareness about cancer pain management. For further details, see: http://www.painpolicy.wisc.edu/publicat/03ejcc/index.htm
Romania: Collaborative efforts have identified and removed regulatory barriers to the modern medical use of opioid analgesics for cancer and AIDS; the Ministry of Health approved proposed regulations and implemented a new law that was adopted by the Romanian parliament late in 2005. For details, see: www.painpolicy.wisc.edu/publicat/06lancet/index.htm
Africa: PPSG is partnering with the African Palliative Care Association and others to sponsor regional workshops for teams of health professionals and drug regulators from Sub-Saharan African countries; the teams use the WHO Guidelines to develop action plans for improving national policy. See: http://www.apca.co.ug/advocacy/workshop/index.htm
Mind the Gap
Experts in oncology and palliative care are familiar with the gap between what is known about pain relief, and what pain relief is actually offered. Another gap is becoming apparent: the gap between the need to relieve severe pain in millions of patients and the unavailability of opioids to most of the world’s population. This gap is not due to inadequate supply of opioids — the answer is not to calculate how much is needed and then simply provide it to each country. Rather, the unavailability of opioids is due to the inadequate demand for opioids on the part of physicians who fail to prescribe them for their patients’ pain. The reasons behind the weak demand are rooted in factors with which we are all familiar: lack of awareness about pain relief; reluctance to prescribe opioids because pain relief is not a priority, or lack of knowledge about pain and opioids; regulatory restrictions or drug costs that impede availability and patient care, and exaggerated fears of addiction.
PPSG is developing new resources in international pain policy for health care professionals and governments, including an International Pain Policy Fellowship, an internet course and increased technical assistance and collaboration. There is evidence that the barriers can be identified and removed if health professionals work systematically with government. But there is a long way to go.
David Joranson
University of Wisconsin
Wisconsin, USA
References:
(1) World Health Organization. Cancer pain relief. Geneva, Switzerland: World Health Organization; 1986. http://www.who.int/cancer/palliative/
(2) World Health Organization HIV-AIDS. Palliative Care. Geneva, Switzerland: World Health Organization; 2004. http://www.who.int/hiv/topics/palliative/care/en/
(3) World Health Assembly. Cancer Prevention and Control. WHA 58.22 Geneva, Switzerland: World Health Organization; 2005. http://www.who.int/gb/ebwha/pdf_files/WHA58-REC1/english/A58_2005_REC1-en.pdf
(4) United Nations Economic and Social Council. Treatment of pain using opioid analgesics; Resolution 2005-25. Report on the forty-eighth session of the Commission on Narcotic Drugs E/2005/28; 19 March 2004 and 7-11 March 2005; issued 22 July 2005.
http://www.un.org/docs/ecosoc/documents/2005/resolutions/Resolution%202005-25.pdf
|
1 |
Austria |
115.7151 |
 |
53 |
Rep. of Korea |
2.0304 |
 |
105 |
Mexico |
0.1957 |
|
2 |
Canada |
64.1751 |
54 |
Tunisia |
1.9579 |
106 |
Azerbaijan |
0.1810 |
|
3 |
Denmark |
63.0390 |
55 |
Ukraine |
1.8003 |
107 |
Turkey |
0.1785 |
|
4 |
Australia |
55.9482 |
56 |
Latvia |
1.7505 |
108 |
Dominica |
0.1714 |
|
5 |
New Zealand |
54.8074 |
57 |
Bahamas |
1.3943 |
109 |
Ecuador |
0.1615 |
|
6 |
United
States of America |
48.8145 |
58 |
Jamaica |
1.3806 |
110 |
Grenada |
0.1584 |
|
7 |
Iceland |
43.9204 |
59 |
Malaysia |
1.3013 |
111 |
Mauritius |
0.1521 |
|
8 |
France |
41.8355 |
60 |
Macao |
1.2809 |
112 |
Turkmenistan |
0.1443 |
|
9 |
Norway |
35.4423 |
61 |
Singapore |
1.2174 |
113 |
Swaziland |
0.1437 |
|
10 |
Sweden |
28.4913 |
62 |
Lebanon |
1.1213 |
114 |
Kenya |
0.1400 |
|
11 |
Switzerland |
26.5509 |
63 |
Argentina |
1.0753 |
115 |
Wallis
& Futuna Islands |
0.1333 |
|
12 |
Falkland
Islands |
22.6667 |
64 |
Republic
of Moldova |
0.8212 |
116 |
Syrian
Arab Republic |
0.1244 |
|
13 |
United
Kingdom |
19.1548 |
65 |
Bahrain |
0.7344 |
117 |
Vanuatu |
0.1238 |
|
14 |
Netherlands |
17.8260 |
66 |
Oman |
0.7175 |
118 |
Chad |
0.1197 |
|
15 |
Germany |
16.0119 |
67 |
United
Arab Emirates |
0.7053 |
119 |
Colombia |
0.1176 |
|
16 |
Saint
Helena |
13.2000 |
68 |
Panama |
0.6261 |
120 |
Morocco |
0.1153 |
|
17 |
Ireland |
12.8478 |
69 |
Greece |
0.6068 |
121 |
Kyrgyzstan |
0.1111 |
|
18 |
Gibraltar |
12.2069 |
70 |
Zimbabwe |
0.5718 |
122 |
Viet
Nam |
0.0993 |
|
19 |
Spain |
11.8115 |
71 |
Belarus |
0.5606 |
123 |
Anguilla |
0.0833 |
|
20 |
Belgium |
10.4698 |
72 |
Mongolia |
0.5511 |
124 |
Nauru |
0.0833 |
|
21 |
Portugal |
7.9790 |
73 |
Thailand |
0.5421 |
125 |
Uzbekistan |
0.0713 |
|
22 |
Poland |
6.1887 |
74 |
Paraguay |
0.5353 |
126 |
Zambia |
0.0704 |
|
23 |
Czech
Republic |
5.7657 |
75 |
Botswana |
0.5200 |
127 |
Mali |
0.0665 |
|
24 |
New Caledonia |
5.6591 |
76 |
Brunei
Darussalam |
0.5200 |
128 |
Egypt |
0.0588 |
|
25 |
Finland |
5.4013 |
77 |
Jordan |
0.4981 |
129 |
Algeria |
0.0546 |
|
26 |
Italy |
5.3206 |
78 |
Dominican
republic |
0.4752 |
130 |
Libyan
Arab Jamahiriya |
0.0527 |
|
27 |
Israel |
5.0158 |
79 |
Kazakhstan |
0.4727 |
131 |
Marshall
Islands |
0.0526 |
|
28 |
Bulgaria |
4.9697 |
80 |
Micronesia
(Fed. States of) |
0.4500 |
132 |
Bolivia |
0.0524 |
|
29 |
French
Polynesia |
4.9069 |
81 |
Saudi
Arabia |
0.4463 |
133 |
Bhutan |
0.0461 |
|
30 |
Japan |
4.7174 |
82 |
Bosnia
& Herzegovina |
0.4332 |
134 |
Guatemala |
0.0333 |
|
31 |
South
Africa |
4.6682 |
83 |
Sri Lanka |
0.4248 |
135 |
Myanmar |
0.0327 |
|
32 |
Estonia |
4.5458 |
84 |
Peru |
0.4163 |
136 |
Cape
Verde |
0.0217 |
|
33 |
Form.
Yug. Rep. of Macedonia |
4.3582 |
85 |
Uganda |
0.4001 |
137 |
Indonesia |
0.0180 |
|
34 |
Slovenia |
4.3210 |
86 |
Cook
Islands |
0.3889 |
138 |
Senegal |
0.0157 |
|
35 |
Slovakia |
4.3185 |
87 |
Tonga |
0.3861 |
139 |
Rwanda |
0.0136 |
|
36 |
Barbados |
3.8044 |
88 |
Republic
of Palau |
0.3500 |
140 |
Nepal |
0.0126 |
|
37 |
Hong
Kong SAR |
3.4817 |
89 |
Qatar |
0.3380 |
141 |
Benin |
0.0112 |
|
38 |
Uruguay |
3.3350 |
90 |
Kuwait |
0.3376 |
142 |
Yemen |
0.0100 |
|
39 |
Malta |
3.2581 |
91 |
Montserrat |
0.3333 |
143 |
Cambodia |
0.0098 |
|
40 |
Costa
Rica |
3.2375 |
92 |
Nicaragua |
0.3280 |
144 |
Burundi |
0.0080 |
|
41 |
Brazil |
3.0848 |
93 |
Iran
(Islamic Republic of) |
0.3277 |
145 |
Cameroon |
0.0076 |
|
42 |
Andorra |
3.0000 |
94 |
United
Republic of Tanzania |
0.3250 |
146 |
Sao Tome
& Principe |
0.0065 |
|
43 |
Namibia |
2.8653 |
95 |
China |
0.3221 |
147 |
Central
African Republic |
0.0048 |
|
44 |
Georgia |
2.7498 |
96 |
British
Virgin Islands |
0.3182 |
148 |
Côte
d’Ivoire |
0.0032 |
|
45 |
Cyprus |
2.7115 |
97 |
Saint
Vincent & the Grenadines |
0.2963 |
149 |
Dem.
Rep. of the Congo |
0.0031 |
|
46 |
Seychelles |
2.6627 |
98 |
Venezuela |
0.2961 |
150 |
Sierra
Leone |
0.0028 |
|
47 |
Hungary |
2.5857 |
99 |
Russian
Federation |
0.2807 |
151 |
Eritrea |
0.0021 |
|
48 |
Lithuania |
2.4867 |
100 |
Guinea-Bissau |
0.2368 |
152 |
Burkina
Faso |
0.0016 |
|
49 |
Chile |
2.4758 |
101 |
El Salvador |
0.2303 |
153 |
Pakistan |
0.0013 |
|
50 |
Romania |
2.4616 |
102 |
Turks
& Caicos Islands |
0.2273 |
154 |
Guinea |
0.0011 |
|
51 |
Serbia
& Montenegro |
2.0794 |
103 |
Suriname |
0.2183 |
155 |
Mozambique |
0.0006 |
|
52 |
Netherlands
Antilles |
2.0447 |
104 |
Philippines |
0.2182 |
|
|
|
| Table
1. Global Morphine Consumption, 2004 (mg/capita). Note: Countries
not listed did not report morphine consumption to the International
Narcotics Control Board (INCB) for 2004. Source: INCB; United
Nations Demographic Yearbook. |
|
 |
|